Anacleto M. Argayosa, PhD Dr. Anacleto Argayosa is currently a Trinitian Research Fellow. From 2018-23, he served as the professor and chair of the Biology Department at TUA's College of Arts, Sciences, and Education. He obtained his Bachelor of Science in Biology from the University of Santo Tomas in 1989. His research career began as a University Research Associate at the Natural Sciences Research Institute at the University of the Philippines Diliman, where he worked on ssue culture and free-living amoebae for four years. Dr. Argayosa's academic journey continued at the Institute of Biology, U.P. Diliman, from 1993 to 2014, where he served as an instructor and later as an assistant professor, earning his Master’s degree in 1999. He was also a visiting scholar at the Johns Hopkins University from 2003-04, conducting dissertation research on carbohydrate-binding proteins and lectin probes in Dr. Yuan C. Lee's glycobiology lab. He completed his PhD in Biology at the University of the Philippines Diliman in 2006. Dr. Argayosa and his research team authored a patent for an oral vaccine delivery system which won the grand prize in the Alfredo M. Yao Na onal Intellectual Property Award in 2013. He has published in peer-reviewed journals such as Fron ers in Microbiology, Fish and Shellfish Immunology, among others. In addition to his research, Dr. Argayosa had received training and travel grants, for a workshop on proteomics at Osaka University in 2007 and participation to the International Society for Developmental and Comparative Immunology conferences abroad. In 2015-16, Dr. Argayosa taught at the University of Santo Tomas as an assistant professor. In 2017, he briefly led the Cellular Therapeutics Unit at Makati Medical Center, applying his expertise in cell biology techniques to clinical research. Dr Argayosa has secured a grant from the Department of Science and Technology in 2022-24 and was able to establish a bioreactor facility at TUA, collaborating with government agencies and industry partners to develop and deploy fish oral vaccine against bacterial pathogens. On June 2024, Dr. Argayosa founded Triune Innovations OPC, a start up company engaged in the development and manufacturing of fish oral vaccines to increase fish produc on towards One Health. This initiative addresses challenges in the aquaculture sector, particularly high mortality rates due to bacterial infections in fish species like tilapia. Through innovative solutions, Triune Innovations OPC aims to enhance sustainability and productivity in fish farming, contributing to economic growth and food security in the country.